Table 1 Patients’ baseline characteristics stratified by treatment assignment. Data are expressed as mean (SD), unless otherwise specified

Age, years

62.5 (4.3)

49.2 (13.1)

Gender, n (% female)

4 (67)

0 (0)

Weight, kg

101 (20.0)

84 (9.5)

Height, cm

175 (7.6)

180 (8.4)

Body mass index, kg/cm²

33 (5.0)

26 (4.4)

Non-Hispanic, n (%)

6 (100)

5 (83)

Diabetes, n (%)

0 (0)

1 (17)

Hypertension, n (%)

6 (100)

3 (50)

Smoking status, n (%)

3 (50)

2 (33)

CVA, n (%)

2 (33)

0 (0)

Anti-platelet therapy, n (%)

4 (67)

2 (33)

ASA score ≥ 4, n (%)

6 (100)

4 (67)

 BUN

20 (9.4)

19 (2.8)

 Creatinine (mg/dL)

0.89 (0.3)

1.13 (0.2)

 Hematocrit (%)

39 (1.7)

43 (2.5)

 Platelet count (K/cu)

203 (62)

194 (16)

 aPTT

44 (34)

27 (3)

 INR

1.05 (0.1)

1.01 (0)

 Fibrinogen (mg/dL)

403 (63)

337 (100)